Portée et taille du marché mondial des médicaments pour le traitement de la fibromyalgie

Le marché des médicaments pour le traitement de la fibromyalgie est segmenté par type et par application. Les acteurs, parties prenantes et autres acteurs du marché mondial des médicaments pour le traitement de la fibromyalgie pourront prendre le dessus en utilisant ce rapport comme une ressource précieuse. L'analyse segmentaire se concentre sur le chiffre d'affaires et les prévisions par type et par application pour la période 2019-2035.

Segment de marché par type : le produit peut être divisé en :

Cymbalta (Duloxétine)

Savella (Milnacipran)

Lyrica (Prégabaline)

Pancuronium

Autres

Segment de marché par application, divisé en :

Hôpital

Clinique

Ménage

Autres

Basé sur

 

Principaux points saillants du rapport de marché :

• Prévisions de Global and China Fibromyalgia Treatment Drug Market Insights jusqu'en 2033
• La taille mondiale and China Fibromyalgia Treatment Drug Market devrait connaître la croissance la plus rapide au cours de la période de prévision.
• Pourquoi le and China Fibromyalgia Treatment Drug Market domine
• Prévisions de taille et de croissance du marché : analyse complète de la taille actuelle du marché, des données historiques et des projections futures pour la période de prévision.
• Tendances et innovations émergentes : analyse approfondie des dernières innovations, des technologies disruptives et de l’évolution des préférences des consommateurs qui façonnent l’avenir de l’industrie.
• Aperçus régionaux : couverture approfondie des principales régions, notamment l'Amérique du Nord, l'Europe, l'Asie-Pacifique, l'Amérique latine, le Moyen-Orient et l'Afrique, ainsi qu'une analyse au niveau des pays.
• Analyse SWOT
• Moteurs et défis du marché : exploration des principaux facteurs qui stimulent la croissance du marché, ainsi que des défis et des risques potentiels.
• Comment trouver les lacunes du marché et les opportunités commerciales
• Paysage concurrentiel : profil détaillé des principaux acteurs, de leur part de marché, de leurs initiatives stratégiques, de leurs fusions et acquisitions et des développements récents.

 

Analyse concurrentielle :

Le rapport propose une analyse pertinente des principaux marchés et entreprises concernés, incluant une présentation générale de l'activité, une présence géographique, des stratégies commerciales, des parts de marché sectorielles et une analyse SWOT. Le rapport and China Fibromyalgia Treatment Drug Market fournit également une analyse détaillée de l'actualité et des développements des entreprises, notamment le développement de modèles, les innovations, les coentreprises, les partenariats, les fusions et acquisitions, les alliances stratégiques, etc. Cela permet d'évaluer la concurrence globale sur le marché.

 

Acteurs clés :

Pfizer Eli Lilly Actavis Generics Merck Sharp and Dohme Daiichi Sankyo Innovative Med Concepts Meda Meiji Seika Switch Biotech Theravance Zynerba Pharmaceuticals Tonix Pharmaceuticals Holding Corp. (TNXP) Daiichi Sankyo Forest Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Pierre Fabre Medicament

 

List of Tables

Table 1. Global Fibromyalgia Treatment Drug Market Size Growth Rate by Type (US$ Million): 2024 Vs 2035

Table 3. Key Players of Cymbalta (Duloxetine)

Table 4. Key Players of Savella (Milnacipran)

Table 5. Key Players of Lyrica (Pregabalin)

Table 6. Key Players of Pancuronium

Table 7. Key Players of Others

Table 8. Global Fibromyalgia Treatment Drug Market Size Growth by Application (US$ Million): 2024 Vs 2035

Table 9. Global Fibromyalgia Treatment Drug Market Size by Regions (US$ Million): 2024 Vs 2035

Table 10. Global Fibromyalgia Treatment Drug Market Size by Regions (2019-2024) (US$ Million)

Table 11. Global Fibromyalgia Treatment Drug Market Share by Regions (2019-2024)

Table 12. Global Fibromyalgia Treatment Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 13. Global Fibromyalgia Treatment Drug Market Share by Regions (2021-2026)

Table 14. Fibromyalgia Treatment Drug Market Market Trends

Table 15. Fibromyalgia Treatment Drug Market Drivers

Table 16. Fibromyalgia Treatment Drug Market Challenges

Table 17. Fibromyalgia Treatment Drug Market Restraints

Table 18. Global Fibromyalgia Treatment Drug Revenue by Players (2019-2024) (US$ Million)

Table 19. Global Fibromyalgia Treatment Drug Market Share by Players (2019-2024)

Table 20. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment Drug as of 2019)

Table 21. Global Fibromyalgia Treatment Drug by Players Market Concentration Ratio (CR5 and HHI)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Fibromyalgia Treatment Drug Product Solution and Service

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Fibromyalgia Treatment Drug Market Size by Type (2019-2024) (US$ Million)

Table 26. Global Fibromyalgia Treatment Drug Market Size Share by Type (2019-2024)

Table 27. Global Fibromyalgia Treatment Drug Revenue Market Share by Type (2021-2026)

Table 28. Global Fibromyalgia Treatment Drug Market Size Share by Application (2019-2024)

Table 29. Global Fibromyalgia Treatment Drug Market Size by Application (2019-2024) (US$ Million)

Table 30. Global Fibromyalgia Treatment Drug Market Size Share by Application (2021-2026)

Table 31. North America Fibromyalgia Treatment Drug Market Size by Type (2019-2024) (US$ Million)

Table 32. North America Fibromyalgia Treatment Drug Market Share by Type (2019-2024)

Table 33. North America Fibromyalgia Treatment Drug Market Size by Application (2019-2024) (US$ Million)

Table 34. North America Fibromyalgia Treatment Drug Market Share by Application (2019-2024)

Table 35. North America Fibromyalgia Treatment Drug Market Size by Country (US$ Million) (2019-2024)

Table 36. North America Fibromyalgia Treatment Drug Market Share by Country (2019-2024)

Table 37. Europe Fibromyalgia Treatment Drug Market Size by Type (2019-2024) (US$ Million)

Table 38. Europe Fibromyalgia Treatment Drug Market Share by Type (2019-2024)

Table 39. Europe Fibromyalgia Treatment Drug Market Size by Application (2019-2024) (US$ Million)

Table 40. Europe Fibromyalgia Treatment Drug Market Share by Application (2019-2024)

Table 41. Europe Fibromyalgia Treatment Drug Market Size by Country (US$ Million) (2019-2024)

Table 42. Europe Fibromyalgia Treatment Drug Market Share by Country (2019-2024)

Table 43. China Fibromyalgia Treatment Drug Market Size by Type (2019-2024) (US$ Million)

Table 44. China Fibromyalgia Treatment Drug Market Share by Type (2019-2024)

Table 45. China Fibromyalgia Treatment Drug Market Size by Application (2019-2024) (US$ Million)

Table 46. China Fibromyalgia Treatment Drug Market Share by Application (2019-2024)

Table 47. China Fibromyalgia Treatment Drug Market Size by Region (US$ Million) (2019-2024)

Table 48. China Fibromyalgia Treatment Drug Market Share by Region (2019-2024)

Table 49. Japan Fibromyalgia Treatment Drug Market Size by Type (2019-2024) (US$ Million)

Table 50. Japan Fibromyalgia Treatment Drug Market Share by Type (2019-2024)

Table 51. Japan Fibromyalgia Treatment Drug Market Size by Application (2019-2024) (US$ Million)

Table 52. Japan Fibromyalgia Treatment Drug Market Share by Application (2019-2024)

Table 53. Japan Fibromyalgia Treatment Drug Market Size by Country (US$ Million) (2019-2024)

Table 54. Japan Fibromyalgia Treatment Drug Market Share by Country (2019-2024)

Table 55. Southeast Asia Fibromyalgia Treatment Drug Market Size by Type (2019-2024) (US$ Million)

Table 56. Southeast Asia Fibromyalgia Treatment Drug Market Share by Type (2019-2024)

Table 57. Southeast Asia Fibromyalgia Treatment Drug Market Size by Application (2019-2024) (US$ Million)

Table 58. Southeast Asia Fibromyalgia Treatment Drug Market Share by Application (2019-2024)

Table 59. Southeast Asia Fibromyalgia Treatment Drug Market Size by Country (US$ Million) (2019-2024)

Table 60. Southeast Asia Fibromyalgia Treatment Drug Market Share by Country (2019-2024)

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Product

Table 64. Pfizer Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Eli Lilly Company Details

Table 67. Eli Lilly Business Overview

Table 68. Eli Lilly Product

Table 69. Eli Lilly Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 70. Eli Lilly Recent Development

Table 71. Actavis Generics Company Details

Table 72. Actavis Generics Business Overview

Table 73. Actavis Generics Product

Table 74. Actavis Generics Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 75. Actavis Generics Recent Development

Table 76. Merck Sharp and Dohme Company Details

Table 77. Merck Sharp and Dohme Business Overview

Table 78. Merck Sharp and Dohme Product

Table 79. Merck Sharp and Dohme Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 80. Merck Sharp and Dohme Recent Development

Table 81. Daiichi Sankyo Company Details

Table 82. Daiichi Sankyo Business Overview

Table 83. Daiichi Sankyo Product

Table 84. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 85. Daiichi Sankyo Recent Development

Table 86. Innovative Med Concepts Company Details

Table 87. Innovative Med Concepts Business Overview

Table 88. Innovative Med Concepts Product

Table 89. Innovative Med Concepts Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 90. Innovative Med Concepts Recent Development

Table 91. Meda Company Details

Table 92. Meda Business Overview

Table 93. Meda Product

Table 94. Meda Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 95. Meda Recent Development

Table 96. Meiji Seika Business Overview

Table 97. Meiji Seika Product

Table 98. Meiji Seika Company Details

Table 99. Meiji Seika Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 100. Meiji Seika Recent Development

Table 101. Switch Biotech Company Details

Table 102. Switch Biotech Business Overview

Table 103. Switch Biotech Product

Table 104. Switch Biotech Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 105. Switch Biotech Recent Development

Table 106. Theravance Company Details

Table 107. Theravance Business Overview

Table 108. Theravance Product

Table 109. Theravance Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 110. Theravance Recent Development

Table 111. Zynerba Pharmaceuticals Company Details

Table 112. Zynerba Pharmaceuticals Business Overview

Table 113. Zynerba Pharmaceuticals Product

Table 114. Zynerba Pharmaceuticals Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 115. Zynerba Pharmaceuticals Recent Development

Table 116. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details

Table 117. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview

Table 118. Tonix Pharmaceuticals Holding Corp. (TNXP) Product

Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development

Table 121. Daiichi Sankyo Company Details

Table 122. Daiichi Sankyo Business Overview

Table 123. Daiichi Sankyo Product

Table 124. Daiichi Sankyo Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 125. Daiichi Sankyo Recent Development

Table 126. Forest Pharmaceuticals, Inc. Company Details

Table 127. Forest Pharmaceuticals, Inc. Business Overview

Table 128. Forest Pharmaceuticals, Inc. Product

Table 129. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 130. Forest Pharmaceuticals, Inc. Recent Development

Table 131. Boehringer Ingelheim GmbH Company Details

Table 132. Boehringer Ingelheim GmbH Business Overview

Table 133. Boehringer Ingelheim GmbH Product

Table 134. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 135. Boehringer Ingelheim GmbH Recent Development

Table 136. Pierre Fabre Medicament Company Details

Table 137. Pierre Fabre Medicament Business Overview

Table 138. Pierre Fabre Medicament Product

Table 139. Pierre Fabre Medicament Revenue in Fibromyalgia Treatment Drug Business (2019-2024) (US$ Million)

Table 140. Pierre Fabre Medicament Recent Development

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Fibromyalgia Treatment Drug Market Share by Type: 2024 Vs 2035

Figure 2. Cymbalta (Duloxetine) Features

Figure 3. Savella (Milnacipran) Features

Figure 4. Lyrica (Pregabalin) Features

Figure 5. Pancuronium Features

Figure 6. Others Features

Figure 7. Global Fibromyalgia Treatment Drug Market Share by Application: 2024 Vs 2035

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Household Case Studies

Figure 11. Others Case Studies

Figure 12. Fibromyalgia Treatment Drug Report Years Considered

Figure 13. Global Fibromyalgia Treatment Drug Market Size (US$ Million), YoY Growth 2019-2035

Figure 14. Global Fibromyalgia Treatment Drug Market Share by Regions: 2024 Vs 2035

Figure 15. Global Fibromyalgia Treatment Drug Market Share by Regions (2021-2026)

Figure 16. Global Fibromyalgia Treatment Drug Market Share by Players in 2019

Figure 17. Global Top Fibromyalgia Treatment Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Treatment Drug as of 2019

Figure 18. The Top 10 and 5 Players Market Share by Fibromyalgia Treatment Drug Revenue in 2019

Figure 19. North America Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 20. United States Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 21. Canada Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 22. Europe Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 23. Germany Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 24. France Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 25. U.K. Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 26. Italy Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 27. Russia Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 28. Nordic Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 29. Rest of Europe Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 30. Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 31. China Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 32. Japan Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 33. South Korea Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 34. Southeast Asia Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 35. India Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 36. Australia Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 37. Rest of Asia-Pacific Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 38. Latin America Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 39. Mexico Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 40. Brazil Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 41. Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 42. Turkey Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 43. Saudi Arabia Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 44. UAE Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 45. Rest of Middle East & Africa Fibromyalgia Treatment Drug Market Size YoY Growth (2019-2035) & (US$ Million)

Figure 46. Pfizer Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 47. Eli Lilly Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 48. Actavis Generics Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 49. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 50. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 51. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 52. Meda Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 53. Meiji Seika Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 54. Switch Biotech Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 55. Theravance Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 56. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 57. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 58. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 59. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 61. Pierre Fabre Medicament Revenue Growth Rate in Fibromyalgia Treatment Drug Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed